Source: Annual Congress 2006 - Epidemiology, risk factors, co-morbidity and systemic side effects of asthma therapy
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. A. Halinska, Y. M. Mostovoy, N. S. Slepchenko, H. V. Demchuk (Vinnitsa, Ukraine). Chlamydia pneumoniae association of patients with bronchial asthma (BA). Eur Respir J 2006; 28: Suppl. 50, 1849

Member's Comments

No comment yet.

Related content which might interest you: Chlamydia pneumoniae infection in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 52s Year: 2004 The role of Chlamydia pneumoniae infection in bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 681s Year: 2005 The association between Chlamydia pneumoniae chronic infection and inflammation in COPD patients. Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Chlamydia pneumoniae infection in patients with mild asthma Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011 Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma Source: Eur Respir J 2002; 20: 834-840 Year: 2002 Chlamydia pneumoniae and mycoplasma pneumoniae seropositivities in children with bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 849s Year: 2006 Chlamydia pneumoniae infection in asthmatic patients Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Mycoplasma pneumoniae infection of airways in patients with exacerbations of bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 237s Year: 2006 Treatment of patients with bronchial asthma and latent chlamydophila pneumoniae and mycoplasma pneumoniae infections by a doxycycline Source: Eur Respir J 2002; 20: Suppl. 38, 159s Year: 2002 The effect of chlamydia pneumoniae infection on the course of bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 516s Year: 2003 Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae Source: Eur Respir J 2002; 19: 546-556 Year: 2002 Chlamydia pneumoniae infection and severe asthma exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 221s Year: 2002 Prevalence of specific IgE antibodies against Mycoplasma pneumoniae and Chlamydia pneumoniae in extrinsic and intrinsic bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 141s Year: 2001 Diagnostics of chlamydia pneumoniae infection in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 674s Year: 2007 Serologic markers for Chlamydia pneumoniae in acute exacerbation of COPD or asthma Source: Eur Respir J 2003; 22: Suppl. 45, 351s Year: 2003 Incidences of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 144s Year: 2005 Infection with mycoplasma pneumoniae and chlamydia pneumoniae in non-allergic late-onset asthma Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006 Associations of maternal Chlamydia trachomatis infection with wheezing,lung function and asthma in children. Source: International Congress 2018 – Primary ciliary dyskinesia and lung function tests in respiratory morbidities Year: 2018 Chlamydophila pneumoniae and mycoplasma pneumoniae infection of airways in patients with bronchoobstructive diseases Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Chlamydia pneumoniae and their potential role in asthma Source: Eur Respir J 2003; 22: Suppl. 45, 421s Year: 2003